Advertisement
Screener

INTERPACE BIOSCIENCES, INC. (IDXG) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised

2.6 / 5 stars · 47/91 Roast Me

INTERPACE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised

INTERPACE BIOSCIENCES, INC. (IDXG) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 9.00 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-27.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2023-03-27

  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2022-12-31 was 0.00 shares.
  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2022-09-30 was 0.00 shares.
  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2022 was 9.00K shares.
  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2014 was 13.18K shares, a 0.00% change from fiscal 2013.
  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2013 was 13.18K shares, a 65.46% decline from fiscal 2012.
  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2012 was 38.17K shares, a 29.60% increase from fiscal 2011.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month
2022-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27
0.00 shares
derived: sum of 2 quarters · filed 2023-03-27
9.00K shares
10-K · filed 2023-03-27
2022-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
9.00K shares
10-Q · filed 2022-11-14
2022-06-309.00K shares
10-Q · filed 2022-08-15
2014-12-3113.18K shares
10-K · filed 2015-03-05
2013-12-3113.18K shares
10-K · filed 2014-03-06
2012-12-3138.17K shares
10-K · filed 2014-03-06
2011-12-3129.45K shares
10-K · filed 2013-03-15